| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |